Tandem Diabetes Care Inc (TNDM)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 285,035 284,580 284,128 283,679 283,232 282,787 282,345 281,905 281,467 281,032 280,599 280,168 202,984 199,120 195,344 — 0 — — —
Total stockholders’ equity US$ in thousands 313,632 314,000 329,234 338,753 439,947 421,822 449,584 437,382 433,112 389,654 346,085 313,414 366,305 326,544 267,704 207,176 194,979 166,994 145,345 120,962
Debt-to-capital ratio 0.48 0.48 0.46 0.46 0.39 0.40 0.39 0.39 0.39 0.42 0.45 0.47 0.36 0.38 0.42 0.00 0.00 0.00 0.00 0.00

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $285,035K ÷ ($285,035K + $313,632K)
= 0.48

The debt-to-capital ratio of Tandem Diabetes Care Inc has been relatively stable over the past eight quarters, ranging between 0.39 and 0.48. This ratio indicates the proportion of the company's total capital that is financed by debt, with the remainder funded by equity.

The trend shows that the company has maintained a moderate level of debt in relation to its total capital structure. A ratio of 0.48 in the most recent quarter suggests that around 48% of the company's capital is derived from debt sources, while the remaining 52% is from equity.

Consistency in the debt-to-capital ratio can imply a stable financial structure, but it is important for investors and stakeholders to assess this metric in conjunction with other indicators to gain a comprehensive understanding of the company's financial health and risk profile. Further analysis of the company's interest coverage ratio, debt maturity profile, and overall leverage position would provide additional insights into its debt management practices.